- Home
- CD vs ANGO Comparison
CD vs ANGO Comparison
Compare CD & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CD | ANGO |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | United States | United States |
| Employees | 11 | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 448.6M | 530.2M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | CD | ANGO |
|---|---|---|
| Price | $6.11 | $10.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 156.5K | ★ 835.3K |
| Earning Date | 08-31-2023 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $956,830.00 | ★ $307,306,000.00 |
| Revenue This Year | $949,544.10 | $9.11 |
| Revenue Next Year | $14.69 | $4.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 33.48 | 7.26 |
| 52 Week Low | $1.38 | $8.27 |
| 52 Week High | $36.77 | $13.99 |
Technical Indicators
Market Signals| Indicator | CD | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.48 |
| Support Level | N/A | $10.16 |
| Resistance Level | N/A | $10.90 |
| Average True Range (ATR) | 0.00 | 0.66 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 17.53 |
Price Performance
Historical ComparisonAbout CD Chaince Digital Holdings Inc. Ordinary Shares
Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.